Science, Discovery, Tech and Environment · 14 August 2026

CSIR-Indian Institute of Chemical Technology (CSIR-IICT) develops plant-based drug for diabetic foot ulcers

Exam-focused facts from the 14 August 2026 current affairs briefing.

Key facts

  • The CSIR-Indian Institute of Chemical Technology (CSIR-IICT) has developed a phytopharmaceutical from the medicinal plant Gymnema sylvestre for treating diabetic foot ulcers.
  • The therapy also shows potential for managing chronic wounds and inflammatory skin disorders.
  • The research was supported under the CSIR Phytopharmaceutical Mission Phase III.
  • The technology has secured patent protection in India and international jurisdictions.
  • An Investigational New Drug (IND)-ready data package has been generated for the standardised botanical therapeutic.
  • The technology has been transferred to Mumbai-based Viridis Biopharma Pvt. Ltd. for clinical development and regulatory approvals.

View this story in the full daily briefing

Earlier coverage selected by topic similarity to help connect developments over time.

FDA Approves First Oral PCSK9 Inhibitor

The US Food and Drug Administration (FDA) approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, on July 16, 2026. Lipfendra is a once-daily tablet for adults with high LDL cholesterol, including familial…